Skip to main content
Andrew Ghio, MD, Pulmonology, Chapel Hill, NC

Andrew J Ghio MD

Critical Care Medicine, Pleural Disease


Associate Consulting Professor of Medicine, Duke University School of

Join to View Full Profile
  • 101 Manning DrChapel Hill, NC 27514

  • Phone+1 919-966-4996

  • Fax+1 919-843-5515

Are you Dr. Ghio?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Andrew Ghio, MD is a pulmonologist in Chapel Hill, North Carolina. He is currently licensed to practice medicine in North Carolina. He is an Associate Consulting Professor of Medicine at Duke University School of.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1989
  • University of Utah Health
    University of Utah HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1988
  • Natoinal Institute of Occupational - Safety Health
    Natoinal Institute of Occupational - Safety HealthResidency, Occupational Medicine, 1985 - 1985
  • UPMC Medical Education/Mercy
    UPMC Medical Education/MercyResidency, Internal Medicine, 1982 - 1984
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1981 - 1982
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1981

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1988 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Press Mentions

  • UNC Joins National Effort to Study Allergic Reactions to COVID mRNA Vaccines
    UNC Joins National Effort to Study Allergic Reactions to COVID mRNA VaccinesApril 20th, 2021